Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.

Shubham PantMartin SchulerGopa IyerOlaf WittToshihiko DoiShukui QinJosep TaberneroDavid A ReardonChristophe MassardAnna MinchomIwona LugowskaOmar CarranzaDirk ArnoldMartin GutierrezHelen WinterKim StuyckensLauren CrowSaltanat NajmiConstance HammondShibu ThomasAdemi Santiago-WalkerSpyros TriantosHussein SweitiYohann Loriotnull null

Published in: The Lancet. Oncology (2023)

Janssen Research & Development.

Keyphrases

open label
double blind
randomized controlled trial